Global HPV Therapeutic Vaccines Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global HPV therapeutic vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are fuelling the growth of the market include a growing number of cervical cancer patients globally, due to HPV infection, along with growing awareness about health among the people. Moreover, the increasing incidence of HPV is a major driving factor for the market. However, low adoption rates and stringent regulatory policies requiring long-term studies of vaccines and their efficacies are the hindrance factors for the market growth.
To Request a Sample of our Report on Global HPV
Therapeutic Vaccines Market: https://www.omrglobal.com/request-sample/hpv-therapeutic-vaccines-market
Human papillomavirus (HPV) therapeutic vaccines are used to protect against
HPV infections. They are sexually transmitted through the skin and mucous of
the infected person. Sexually transmitted HPV infection can be categorized as
low-risk HPVs and high-risk HPVs. Low-risk HPV causes skin warts around
genitals, anus, mouth, or throat, and could lead to respiratory papillomatosis;
whereas, high-risk HPV causes cancer such as cervical, anal, oropharyngeal
cancers, and other rare cancers. The incidence of genital HPV infections in the
US is approximately 14 million per year. Currently, there are three
FDA-approved HPV therapeutic vaccines available in the market, namely,
Gardasil, Gardasil 9, and Cervarix. These vaccines are effective in preventing
infections caused by two high-risk HPVs (HPV types 16 and 18), which are
responsible for causing about 70% of cervical cancers. Thus, the rise in the
cases of HPV is driving the growth of the market. The key players in the market
are adopting several strategies such as product launches, and mergers and
acquisitions, among others to remain competitive in the market. For instance,
In September 2019, GlaxoSmithKline teamed up with China-based company Xiamen
Innovax Biotech for the development and commercialization of HPV vaccines.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Pfizer Inc.,
GlaxoSmithKline plc, and Merck & Co., Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global HPV Therapeutic Vaccines Market is Available
at: https://www.omrglobal.com/industry-reports/hpv-therapeutic-vaccines-market
Global HPV Therapeutic Vaccines Market Report by Segment
By Adjuvants
• Bivalent HPV
Vaccine
• Quadrivalent HPV Vaccine
Global HPV Therapeutic Vaccines Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment